United StatesThe A71200 Vanta Clinician Programmer Application (CP App), product number A71200, versions 2.0.2465 and 2.0.2683 deployed on Samsung tablets (CFN CT900) is being recalled. Medtronic received complaints that the CP App does not function as intended during use, which could lead to prolonged or postponed surgical procedures. Implanted Vanta neurostimulator devices are not affected.
What's being recalled
A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).
Recalling firm: Medtronic Neuromodulation, Minneapolis, MN, United States.
How to identify it
version 2.0.2465 and 2.0.2683 UDI-DI (GTIN) 00763000520083 Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.
The hazard
Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Worldwide - US Nationwide distribution.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)